תוכנית

Print
 
WEDNESDAY 10 JANUARY, 2018
TIME
POST-GRADUATE DAY
14:00-14:30
Coffee Gathering (Exhibition Area)
14:30-16:00
PARALLEL SESSIONS
Hall B
SESSION 1 | Advanced course IBD: the focus on ulcerative colitis
*supported by Abbvie
Hall A
SESSION 2 | Neurogastroenterology
 
Chairs: Yehuda Chowers, Rambam health care campus and Irit Avni Biron, Rabin medical center
 
Chairs: Ram Dickman, Rabin Medical Center and Dan Carter, Sheba Medical Center
14:30-15:05
Therapeutic dilemmas in ulcerative colitis: Matti Waterman, Rambam Health Care Campus
14:30-14:45
Functional diagnostic tests for pelvic floor disorders: Yishai Ron, Tel Aviv Sourasky Medical Center
15:05-16:00
Ulcerative colitis - Practical strategies, tandem talk: Henit Yanai, Rabin Medical Center and Uri Kopylov, Sheba Medical Center
14:45-15:15
Debate: chronic constipation: Dan Carter, Sheba Medical Center and Ram Dickman, Rabin Medical Center
   
15:15-15:30
Fecal incontinence: the conservative approach: Josef Lysy, Shaare Zedek Medical Center
   
15:30-15:45
Fecal incontinence: the mini surgical approach: Mark Beer-Gabel, Sheba Medical Center
   
15:46-16:00
Panel discussion
16:00-16:30
Coffee Break (Exhibition Area)
16:30-18:00
PARALLEL SESSIONS
Hall B
SESSION 3 | Advanced course IBD: the focus on ulcerative colitis
*supported by Abbvie
Hall A
SESSION 4 | The practicalities of polyps
 
Chairs: Efrat Broide, Assaf Harofeh Medical Center and Eran Zittan, Emek Medical Center
 
Chairs: Guy Rosner, Tel Aviv Sourasky Medical Center and Nadir Arber, Tel Aviv Sourasky Medical Center
16:30-17:50
Ulcerative colitis, interactive case management (IBD Via). Focusing on complications of disease, tandem talk: Eran Israeli, Hadassah Medical Center and Doron Schwartz, Soroka Medical Center
16:30-17:00
Surveillance of polyposis syndromes: Patrick Lynch, The University Of Texas MD Anderson Cancer Center, Houston, TX
17:50-18:00
Q&A
17:00-17:20
Malignant polyp - What should I ask the pathologist and how the answer will guide me in decision making?: Eli Brazowski, Tel Aviv Sourasky Medical Center
   
17:20-17:40
Malignant polyp - The gastroenterologist approach: Amir Klein, Rambam Health Care Campus
   
17:40-18:00
PPIS and gastric cancer - Evidence based medicine or fake news?: Ido Laish, Meir Medical Center
18:00-18:45
Drinks & Mingling ( Exhibition Area)

END OF DAY ONE

       
 
THURSDAY 11 JANUARY, 2018
TIME
 
07:30-08:30
Light Breakfast and Gathering (Exhibition Area)
08:30-10:30
PLENARY SESSION
Hall B
OPENING PLENARY | SESSION 5
 
Chairs Iris Dotan, Rabin Medical Center and Michael Wilschanski, Hadassah Medical Center
08:30-08:45
Opening remarks: Iris Dotan, Rabin Medical Center and Michael Wilschanski, Hadassah Medical Center
08:45-09:15
Information security and cyber: Itzik Kochav, Clalit Health Services
09:15-09:25
Q&A
 
Everything the gastroenterologist should know:
09:25-09:40
Helicobacter Pylori update: Haim Shirin, Assaf Harofeh Medical Center
09:40-09:50
New aspects in children: Michal Kori, Kaplan Medical Center
09:50-10:00
Q&A
10:00-10:20
Chemoprevention of sporadic and hereditary colon cancers: Patrick Lynch, The University Of Texas MD Anderson Cancer Center, Houston, USA
10:20-10:30
Q&A
10:30-11:00
Coffee Break (Exhibition Area)
11:00-12:30
PARALLEL SESSIONS
Hall B
SESSION 6 | Treat to target in IBD: But which target - gut, joints, skin or all?
*supported by Janssen
Hall A
SESSION 7 | Hepatology: updates from the AASLD
*supported by Gilead
Jaffa Hall (M Floor)
SESSION 8 | Pediatric gastroenterology
 
Chair: Shomron Ben-Horin, Sheba Medical Center and Nimrod Kimchi, Bat-Yamon Medical Center
 
Chairs: Eli Zuckerman, Carmel Medical Center and Jorge-Shmuel Delgado, Assuta Ashdod University Hospital
 
Chairs: Michael Wilschanski, Hadassah Medical Center and Ilana Weintraub, Sheba Medical Center
11:00-11:05
Treat to target in IBD: For everyone or no one?: Shomron Ben-Horin, Sheba Medical Center
11:00-11:23
Primary prophylaxis of esophageal variceal bleeding - Update: Eyal Ashkenazi,Carmel Medical Center
11:00-11:10
Abstract V
Genetic and structural analysis of a Skiv2l mutation causing an atypical presentation of Tricho-Hepato-Enteric Syndrome: Iddo Vardi, Edmond and Lily Safra Children’s Hospital
11:05-11:30
Stopping disease progression: Lessons from our rheumatology colleagues: Ziv Paz, The Western Galilee Hospital
11:23-11:33
Abstract III
Endoscopic ultrasound assisted by elastography is highly effective and accurate to detect liver metastases during staging of primary tumors of the upper gastrointestinal tract, including small lesions that were missed by CT scan: Dan Meir Livovsky, Shaare Zedek Medical Center
11:10-11:20
Abstract VI
Risk factors for disease relapse after stepping down from combination to anti-TNF monotherapy in children with IBD: Anat Yerushalmy-Feler, Tel Aviv Sourasky Medical Center
11:30-12:05
Debate: Pro-active or too-active: Should treat-to-target become daily practice for our IBD patients?
Matti Waterman, Rambam Health Care Campus
Eran Israeli, Hadassah Medical Center
11:33-11:56
Non-alcoholic fatty liver disease 2018 - Update: Ziv Ben Ari, Sheba Medical Center
11:20-11:30
Abstract VII
Impaired Il-10 receptor mediated suppression in monocytes from patients with Crohn`s Disease: Moran Yechiel Nunberg, Edmond and Lily Safra Children's Hospital
12:05-12:14
Conclusion: Shomron Ben-Horin, Sheba Medical Center
11:56-12:06
Abstract IV
Cholecystectomy and biliary sphincterotomy increase fecal bile loss and have a beneficial effect on blood lipid profile in severely dyslipidemic patients: Ilia Sergeev, Meir Medical Center
11:30-11:40
Abstract VIII
Manipulating the microbiome in pediatric acute severe colitis with antibiotics cocktail: A pilot randomized controlled trial: Dan Turner, Shaare Zedek Medical Center
12:14-12:22
Abstract I
Endoscopic and histologic findings correlate with free infliximab found in uninflamed tissue in IBD patients: Haggai Bar Yoseph, Technion Israel Institute Of Technology
12:06-12:30
Hepatitis C 2018 – Update: Eli Zuckerman, Carmel Medical Center
11:40-11:50
Abstract IX
Infantile-onset colitis resulting from Rtel1 mutation: Dror Shouval, Pediatric Gastroenterology Unit, Edmond and Lily Safra Children's Hospital
12:22-12:30
Abstract II
Pregnant women with ulcerative colitis are more likely than Crohn`s Disease to exacerbate during pregnancy: Ariella Bar-Gil Shitrit, Shaare Zedek Medical Center
   
11:50-12:00
Abstract X
The biological function of milk derived mirna on intestinal normal and tumor cells: Regina Golan-Gerstl, Hadassah Medical Center
       
12:00-12:30
Optimization of biologic agents treatment in IBD : Amit Assa, Schneider Children's Medical Center
Hall D
SESSION 9 | Nurses
Hall C
SESSION 10 | Administration
 
Chairs: Yuri Guriel, Rambam Health Care Campus and Rachel Leshem, Sheba Medical Center
 
Chairs: Tanir Zion, Rabin Medical Center and Meirav Cohen, Sheba Medical Center
11:00-11:05
Opening remarks: Revital Barkan, Rabin Medical Center
11:00-11:10
דברי פתיחה: איל שחר, המרכז הרפואי אסף הרופא
11:05-11:20
Innovations in the training of gastroenterological nurses: Yuri Guriel, Rambam Health Care Campus
11:10-11:25
סוגיות מדיקו-לגאליות בגסטרואנטרולוגיה: דורון שוורץ, המרכז הרפואי האוניברסיטאי סורוקה
11:20-11:40
The great PPI scare: Tom Konikoff, Rabin Medical Center
11:25-11:40
סודיות ופרטיות המטופל: רפאל ולדן, המרכז הרפואי ע"ש חיים שיבא - תל השומר
11:40-11:55
Factors associated with optimizing bowel preparation for colonoscopy: Eisa Hag, Rambam Health Care Campus
11:40-11:55
פעולות אנדוסקופיות: עדי להט, המרכז הרפואי ע"ש חיים שיבא - תל השומר
11:55-12:10
Nurses perceptions of barriers to optimal nutritional therapy for hospitalized patients: Aviva Alagem Mizrahi, Sheba Medical Center
11:55-12:10
מחלות מעי דלקתיות- תסמינים וטיפולים: הנית ינאי, מרכז רפואי רבין
12:10-12:30
The experience of a nurse-operated referral center for video-capsule endoscopy: Osnat Kalnizki, Assuta Raanana Medical Center
12:10-12:30
הצוות הרב מקצועי: רויטל ברקן, מרכז רפואי רבין
12:30-13:15
Lunch Break (Exhibition Area)
13:15-14:45
LUNCH SYMPOSIA AND SESSION 9+10 CONTINUED
Hall B
SYMPOSIUM A | IBD: Changing perception
*supported by Takeda
Jaffa Hall (M Floor)
SYMPOSIUM B | Pediatric gastroenterology
 
Chairs: Doron Schwartz, Soroka Medical Center and Dan Turner, Shaare Zedek Medical Center
 
Chairs: Orly Eshach Adiv, Rambam Health Care Campus and Baruch Yerushalmi, Soroka Medical Center
13:15-13:20
Welcome and opening remarks: Doron Schwartz, Soroka Medical Center and Dan Turner, Shaare Zedek Medical Center
13:15-13:45
Neonatal Cholestasis 2018: Anil Dhawan, Kings College Hospital, London
13:20-14:05
IBD treatment in 2018: The perception is changing: Gert Van Assche, University Hospital Leuven, Belgium
13:45-13:55
Abstract XIV
Steroid free treatment of autoimmune hepatitis in selected pediatric population: Orith Waisbourd-Zinman, Schneider Children's Medical Center of Israel
14:05-14:15
Q&A
13:55-14:05
Abstract XV
Fecal calprotectin in cystic fibrosis patients during respiratory exacerbation: Ze'ev Schnapp, Carmel Medical Center
14:15-14:23
Abstract XI
Pharmacokinetics and immune re-constitution following discontinuation of thiopurine analogues: Implications for drug withdrawl strategies: Noa Markovits, Sheba Medical Center
14:05-14:15
Abstract XVI
The role of eus and MRI in the differential diagnosis of autoimmune pancreatitis in children; a clinical and morphological study of 17 patients with recurrent non-calcifying pancreatitis: Dan Meir Livovsky, Shaare Zedek Medical Center
14:23-14:31
Abstract XII
Effectiveness and safety of vedolizumab in anti-TNF naïve patients with Inflammatory Bowel Disease - A multicenter retrospective European Crohn`s and colitis organization study: Uri Kopylov, Sheba Medical Center
14:15-14:25
Abstract XVII
Adalimumab induced pancreatitis in a pediatric patient with Crohn`s Disease: Ramit Magen Rimon, Ruth Rappaport Children's Hospital
14:31-14:39
Abstract XIII
Trends in epidemiology of Inflammatory Bowel Disease among jewish israeli adolescents: a population based study: Itai Ghersin, IDF Medical Corps, Tel Hashomer
14:25-14:35
Abstract XVIII
No need the investigation for celiac disease 6 years after the diagnosis of Diabetes Mellitus Type 1: Mordechai Slae, Hadassah-Hebrew University Medical Center
   
14:35-14:45
Abstract XIX
Teduglutide for pediatric patients with intestinal failure- a preliminary report: Avishay Lahad, Edmond and Lily Safra Children’s Hospital
Hall D
SESSION 9 | Nurses (Cont.)
Hall C
SESSION 10 | Administration (Cont.)
 
Chairs: Revital Barkan, Rabin Medical Center and Dganit Avdar Daniel, Hadassa Medical Center
 
Introduction by Tanir Zion, Rabin Medical Center
13:15-13:30
Stem cells treatment for perianal fistulas in CD: Adi Lahat, Sheba Medical Center
13:15-14:15
שיפור השירות וניהולו, הרצאה חווייתית: אסתהר קסלסי
13:30-13:45
A debriefing method to improve gastroenterology nursing practices: Ruhama Podoler, Emek Medical Center
   
13:45-14:00
A specialized IBD unit infusion center is preferred by patients: Betty Mazuz, Shaare Zedek Medical Center
   
14:00-14:15
IBD from pediatrics to adults: Solafa Khamaisi, Ruth Childrens' Hospital Rambam Medical Center
   
14:15-14:30
What’s between LVAD implantation and gastroenterology?: Eti Solomon, Sheba Medical Center
   
14:30-15:30
Winning the daily battles: Ariel (Arik) Ze'evi
   
14:45-15:00
Technical Break
15:00-16:30
PARALLEL SESSIONS
Hall C
SESSION 11 | Mind the gut
Hall A
SESSION 12 | New strategies in GI infections
Hall B
SESSION 13 | Colorectal cancer diagnosis in Israel - a time for national screening programs
 
Chairs: Benny Avidan, Sheba Medical Center and Boris Spoznikov, Hasharon Hospital
 
Chairs: Nitsan Maharshak, Tel Aviv Sourasky Medical Center and Ohad Etzion, Soroka Medical Center
 
Chairs: Hana Strul, Tel Aviv Sourasky Medical Center and Lior Katz, Sheba Medical Center
15:00-15:25
Location Location Location: Henit Yanai, Rabin Medical Center
 
Clostridium difficile infection for gastroenterologists - What is new?
15:00-15:08
Abstract XXIV
Adenoma detection rate analysis at the community setting- on the path for implementation: Revital Kariv, Maccabi Health Care Services, Tel Aviv Sourasky Medical Center, Tel Aviv University
15:25-15:45
Mesalamine is here to stay, tips and tricks: Irit Avni Biron, Rabin medical center
15:00-15:20
New findings, new approaches: Jacob Strahilevitz, Hadassa Medical Center
15:08-15:16
Abstract XXV
"Gammora": selective killing of cancer cells bearing CD-24 by viral integrase: Shiran Shapira, Tel Aviv Sourasky Medical Center
15:45-16:05
Non celiac gluten sensitivity: Raanan Shamir, Schneider Children's Medical Center
15:20-15:35
Encapsulated FMT: Ilan Yungster, Assaf Harofeh Medical Center
15:16-15:26
Fit based national screening program- the rationale: Zohar Levi, Rabin Medical Center
16:05-16:30
What the psyche has to do with the gut? on the psychiatric and the psychological burden of IBD: Yoram Inspector, St Mark's Hospital, UK
15:35-15:43
Discussion
 
Debate: Colonoscopy as a part of the national screening program for CRC
   
15:43-15:58
Emerging therapeutic strategies for Hepatitis Delta Virus: Jeffrey S. Glenn, Stanford University School Of Medicine, USA
15:26-15:36
For: Naim Abu Freha, Soroka Medical Center
   
15:58-16:06
Abstract XX
Using a novel developed high resolution melt curve assay for the analysis of predominance of helicobacter pylori clarithromycin resistance in Israel: Tsachi Tsadok Perets, Rabin Medical Center and Tel Aviv University
15:36-15:46
Against: Revital Kariv, Tel Aviv Sourasky Medical Center
   
16:06-16:14
Abstract XXI
Rapid amelioration of minimal hepatic encephalopathy in HCV patients after effective antiviral treatment: a follow up study: Helena Katchman, Tel Aviv Sourasky Medical Center
15:46-15:55
Discussion
   
16:14-16:22
Abstract XXII
A meta-analysis: chromoendoscopy or white light endoscopy for neoplasia detection in Lynch-syndrome: Ofir Har-Noy, Sheba Medical Center
15:55-16:15
Diagnosis of Lynch syndrome - New Paradigm - From phenotype to genotype: Lior Katz, Sheba Medical Center
   
16:22:16:30
Abstract XXIII
Treatment naïve newly diagnosed patients with Crohn`s disease have microbial dysbiosis correlated with disease activity and fecal calprotectin-results from a prospective inception cohort: Henit Yanai, Rabin Medical Center
16:15-16:30
Universal screening – Practical issues towards implementation in the health basket: Elizabeth Half, Rambam Health Care Campus
16:30-17:00
Coffee Break (Exhibition Area)
17:00-18:30
PLENARY SESSION
HALL B
SESSION 14 | High up
 
Chairs: Adi Lahat, Sheba Medical Center and Eyal Shachar, Assaf Harofeh Medical Center
17:00-17:15
Cannabis in IBD
Abstract XXVI Cannabis induces clinical and endoscopic improvement in moderately active ulcerative colitis (UC): Timna Naftali, Meir Medical Center
17:15-17:35
The MOH cannabis revolution: Michael Dor, Medical Cannabis Unit Ministry Of Health
17:35-17:50
Discussion
17:50-18:20
Inspiring Leadership
Introduction: Iris DotanRabin Medical Center
Inbal Kreiss, Deputy General Manager, Space Division, System Missiles & Space Group
18:20-18:30
Q&A
18:30-19:15
Cocktail (Exhibition Area)
19:15
Entertainment by Tzachi Ben Zion (Hall B)

END OF DAY TWO

                   
 
FRIDAY 12 JANUARY, 2018
TIME
 
06:45-08:00
5K “Gastro” Fun Run Tayelet Tel Aviv (Meeting Point – Lobby)
07:30-08:30
Light Breakfast and Gathering (Exhibition Area)
08:30-09:45
PARALLEL SESSIONS
Hall B
SESSION 15 | Neurogastroenterology
Hall A
SESSION 16 | Nutrition
 
Chairs: Josef Lysy, Shaare Zedek Medical Center and Roy Dekel, Tel Aviv Sourasky Medical Center
 
Chair: Alon Lang, Sheba Medical Center and Mati Shnell, Tel Aviv Sourasky Medical Center
08:30-08:45
Dysphagia – Multidisciplinary approach is the answer: Ram Dickman, Rabin Medical Center
08:30-08:50
Improving medical outcome by supporting muscle: Liat Deutsch (Mlynarsky), Tel Aviv Sourasky Medical Center
08:45-09:03
A case of early satiety and bloating: Tiberiu Hershcovici, Hadassah Medical Center
08:50-09:10
Sport supplements, performance, health and in between..: Ronen Bar-Yoseph, Rambam Health Care Campus
09:03-09:20
Persistent heartburn - What else can be done?: Rita Brun, Rambam Medical Center
09:10-09:30
Saturated fat-harmful or harmless?: Rafael Bitzur, Sheba Medical Center
09:20-09:37
Approach to gas and flatulence: Roy Dekel, Tel Aviv Sourasky Medical Center
09:30-09:38
Abstract XXVII
Dietary interventions may modify intestinal inflammation via altering microbial composition. A cross-over trial: Lihi Godny, Rabin Medical Center
09:37-09:45
Panel discussion
09:38-09:46
Abstract XXVIII
Spatz3 adjustable balloon: The first 551 patients in Israel: Jeffrey Brooks, Optimal Clinic Tel Aviv
09:45-10:15
Coffee Break (Exhibition Area)
10:15-11:20
PARALLEL SESSIONS
Hall B
SESSION 17 | Neurogastroenterology
*supported by Takeda
Hall A
SESSION 18 | Pediatric Gastroenterology
 
Chairs: Mark Beer-Gabel, Sheba Medical Center and Rita Brun, Rambam Medical Center
 
Chairs: Shlomi Cohen, Tel Aviv Sourasky Medical Center and Drora Berkowitz, Bnai Zion Medical Center
10:15-10:30
What to do for IBS when colotal and low FODMAP failed?: Dan Carter, Sheba Medical Center
10:15-10:45
Hepatocyte transplantation: Anil Dhawan, Kings College Hospital, UK
10:30-10:55
Pain management in functional GI disorders: Mark Beer-Gabel, Sheba Medical Center
10:45-10:55
Abstract XXIX
Does the circadian clock have a role in the pathogenesis of Inflammatory Bowel Disease (IBD)?: Yael Weintraub Braha, Tel Aviv Sourasky Medical Center
10:55-11:10
Functional GI disorders - the integrative approach: Nir Salomon, Sheba Medical Center
10:55-11:05
Abstract XXX
The knowledge of teenage patients with Inflammatory Bowel Diseases about their disease - A multi center study: Tal Harel, Sheba Medical Center
11:10-11:20
Coping With IBS In The Social Media Era: Dana Zur, Facebook Group Manager
11:05-11:15
Abstract XXXI
Body Mass Index in the lower or upper quartile is a marker of severe disease course in children with Inflammatory Bowel Disease: Anat Yerushalmy-Feler, Tel Aviv Sourasky Medical Center
   
11:15-11:25
Abstract XXXII
The interelationship between Hepcidin, Vitamin D and Anemia in children with Inflamatory Bowel Disease (IBD): Hadar Moran-Lev, Tel Aviv Sourasky Medical Center
   
11:25-11:35
Abstract XXXIII
Age-of-onset dependent ileal immune maturation and reduced alpha-defensin expression in pediatric Crohn Disease despite stable dysbiosis: Yael Haberman, Sheba Medical Center
   
11:35-11:45
Abstract XXXIV
Prognostic factors for colectomy and acute severe colitis in pediatric ulcerative colitis: a systematic review: Esther Orlanski-Meyer, Shaare Zedek Medical Center
   
11:45
Business Meeting - Pediatric Gastroenterology
11:20-11:25
Technical Break
11:25-12:50
SESSION 19
HALL B
SESSION 19 | Business Meeting
11:25-11:50
Informed consent - are we doing it right? the medicolegal aspect: Adv. Limor Cohen Ashkenazi
11:50-12:00
"Translation" to gastroenterology: Ori Segol, Carmel Medical Center
12:00-12:20
IGA research reports
 
Orly Sneh Arbib, Rabin Medical Center, Itay Maza, Rambam Health Care CampusDror Shouval, Sheba Medical CenterShlomi Cohen, Tel Aviv Sourasky Medical CenterYael Haberman, Sheba Medical Center
12:20-12:40
Report from the "Vaad": Iris Dotan, Rabin Medical Center, Adi Lahat, Sheba Medical Center, Eyal Shachar, Assaf Harofeh Medical Center and Haya Fainguelernt, Meir Medical Center
12:40-12:50
Best Abstracts Award

END OF DAY THREE